INCY
Incyte Corporation$113.36-1.13% 1D· price as of Jun 30, 8:32 PM+60.09% over 1Y
Compare:INCY
Mkt Cap
$22.6B
P/E
16.0×
Fwd P/E
12.3×
PEG
11.68
P/B
4.0×
P/S
4.2×
EV/EBITDA
12.1×
Beta
0.79
Div Yield
0.0%
Payout
0.0%
ROE
30.8%
Net Margin
26.7%
Short % Flt
6.3%
Inst. Own
106.6%
52-wk low $66.83$113.3652-wk high $115.56
+69.6% above low-1.9% from high
Seasonality — avg monthly return
Strongest Jun 5.0% · weakest Feb -5.1%Jan
+2.1
Feb
-5.1
Mar
-2.3
Apr
-0.3
May
-0.3
Jun
+5.0
Jul
+2.8
Aug
+0.9
Sep
-5.0
Oct
+4.9
Nov
+4.3
Dec
+2.4
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Incyte Corporation
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
INCY — recent news
Loading headlines…
Quality scorecard
vs Biotechnology · 8 peers · percentile rank
76 / 100
Strong
ROIC20.1%
57
ROE24.9%
71
Gross margin92.8%
100
Operating margin26.1%
57
FCF yield5.9%
71
Net debt / EBITDAnet cash
100
Percentile vs 8 Biotechnology peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.